Default company panoramic image

Imagistx Inc.

ImagistxProstate is a new ultrasound device tuned specifically for the prostate that dramatically improves cancer detection and treatment.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Toronto, ON, Canada
  • Currency CAD
  • Founded November 2012
  • Employees 5
  • Website

Company Summary

Imagistx has developed an ultra high resolution ultrasound system that provides significant improvements in detecting prostate cancer (as per initial Clinical Study by Johns Hopkins). The system will be sold to private practice urologists, hospitals and imaging centers. Imagistx is now running a multi-site 960-patient clinical study that will statistically prove the superiority of the system against the standard of care and drive up adoption.


  • Default avatar
    Randy William AuCoin

    Randy AuCoin has extensive experience in all aspects of company operations from his involvement in three previous early stage companies.
    1990 - 1998: Principal Engineer at Biomedical Instrumentation, acquired by American Home Products in 1993 (and renamed Quinton Electrophysiology).
    1998 - 2000 Consultant
    2000 - 2003 Manager, Eng/QA/RA at Dicomit, acquired by Cedara Software.
    2003 - 2011 VP, QA/RA at VisualSonics, acquired by SonoSite June 20


  • Default avatar
    Stikeman Elliott

Previous Investors

  • Default avatar
    iGan Partners